Not medical advice. Talk to your provider before using any peptide. Full disclaimer
Peptide Schedule Research TeamReviewed Apr 7, 20268 Citations
Exenatide (Byetta / Bydureon) Dosage Calculator
Weight Loss · FDA Approved · Grade A · 2.4 h half-life · Injection
Exenatide (Byetta / Bydureon) Dosage
| Level | Dose / Injection | Frequency |
|---|---|---|
| Beginner | 5 mcg | 2x Daily |
| Moderate | 10 mcg | 2x Daily |
| Aggressive | 2 mg | Weekly |
Cycle: No scheduled off period.
No syringe calculation for this route
Subcutaneous
Exenatide (Byetta / Bydureon) has no default water volume for this calculator, so there are no syringe units to calculate here. Dosing runs 5 mcg to 2000 mcg per administration, 2x daily.
If your product does arrive as a powder, use the universal reconstitution calculator and enter your own vial size and water volume.
About Exenatide (Byetta / Bydureon)
Beginner, moderate, and aggressive dosing amounts with timing. Free to use.
Exenatide was the first FDA-approved GLP-1 receptor agonist for type 2 diabetes. Both Byetta (twice daily) and Bydureon (weekly) were discontinued in October 2024. Complete clinical data, side effect profile, and transition guidance covered here. A generic exenatide injection (ANDA 206697) has been FDA-approved since November 2024.
View side effects and safety warnings →
Quick-Start: How to Use Exenatide (Byetta / Bydureon)
- 1Check the pen. Byetta pens should contain clear, colorless solution. Bydureon suspension will look cloudy after mixing. Discard if you see particles, discoloration, or the expiration date has passed.
- 2Choose your injection site: abdomen, upper thigh, or back of the upper arm. Rotate sites each injection. Clean the area with an alcohol swab and let it dry.
- 3Attach a new pen needle. For Byetta, a 31-gauge, 6mm or 8mm needle works well. Remove both the outer and inner needle caps.
Exenatide (Byetta / Bydureon) Dosing Protocol
| Level | Dose / Injection | Frequency |
|---|---|---|
| Beginner | 5 mcg | 2x Daily |
| Moderate | 10 mcg | 2x Daily |
| Aggressive | 2 mg | Weekly |
Both Byetta and Bydureon BCise were permanently discontinued in October 2024. Drugs@FDA lists a generic exenatide injection from Amneal (ANDA 206697, approved November 19, 2024) as an active prescription product. If you still have pens from before the discontinuation, check the expiration date and don't use anything past it.
Byetta came as pre-filled pens. No reconstitution needed. The 5 mcg pen delivered 60 doses (one month at twice daily); the 10 mcg pen also delivered 60 doses. No bacteriostatic water, no insulin syringes, no mixing. Refrigerate before first use; after that, room temperature up to 30 degrees C for 30 days.
Bydureon required reconstituting a microsphere suspension immediately before injection. It came in single-dose kits. The BCise autoinjector simplified this, but neither can be replicated by a compounding pharmacy.
The biggest mistake most beginners made was timing. Inject within 60 minutes before the meal, not after. If you took it after eating, nausea got worse and glucose control suffered. Keep the two daily doses at least 6 hours apart.
If you're on oral medications like antibiotics or birth control pills, take those at least one hour before your exenatide injection. The gastric emptying delay will slow their absorption otherwise. For anyone currently searching for exenatide: transition to semaglutide or tirzepatide with prescriber guidance.
Dosing based on Byetta (exenatide) FDA Prescribing Information (2014): 8 published references.View all sources →
Ask AI about this math
Cross-check your Exenatide (Byetta / Bydureon) reconstitution math with AI
Exenatide (Byetta / Bydureon) Cost
Pricing updated 2026-04-09
Prices are estimates and vary by source, location, and prescription status.Full pricing breakdown →
Exenatide (Byetta / Bydureon) Pharmacokinetics
Pharmacokinetics: Active Dose Over Time
t½ = ~2.4 hours (Byetta IR); ~2 weeks sustained release (Bydureon ER)Disclaimer: This curve is a simplified first-order exponential decay model. Actual pharmacokinetics vary based on injection site, individual metabolism, body composition, and other factors. Half-life values are approximate and based on available preclinical and clinical literature. Many research peptides lack formal human pharmacokinetic studies. This is for educational purposes only, not medical advice.
Related Tools
Frequently Asked Questions
How popular is Exenatide (Byetta / Bydureon)?
Niche. A popularity tier (hot, popular, emerging or niche), based on search volume and community activity.
Reddit: Low. Community mentions on Reddit: Low-moderate historical; declining since discontinuation.
1,200 papers on PubMed, the US library of medical research. Search them on PubMed (opens in a new tab).
Moderate search interest. A band for how often people search Google for the name each month.
These come from this site's peptide records. They are not live counts.